Vion Pharmaceuticals (VION) Receives Response From FDA on Special Protocol Assessment for Onrigin(TM)
3/1/2010 8:01:42 AM
More...
|
Vion Pharmaceuticals (VION) Issues Management Statement Regarding Trading Volume of Company's Common Stock
1/25/2010 10:00:44 AM
More...
|
Vion Pharmaceuticals (VION) Announces Filing of Special Protocol Assessment for Onrigin(TM)
1/12/2010 11:13:50 AM
More...
|
Vion Pharmaceuticals (VION) Announces FDA Conclusion; HOVON Trial As Designed Does Not Gain SPA Agreement
12/30/2009 6:52:25 AM
More...
|
Vion Pharmaceuticals (VION) Files for Chapter 11 Bankruptcy After FDA Rejects Drug
12/18/2009 7:34:10 AM
More...
|
Vion Pharmaceuticals (VION) Receives Complete Response Letter for Onrigin(TM) From FDA
12/14/2009 10:19:00 AM
More...
|
Vion Pharmaceuticals (VION) Reports 2009 Third Quarter and Nine-Month Results Company to hold Conference Call on November 12, 2009
11/11/2009 7:46:21 AM
More...
|
Vion Pharmaceuticals (VION) Engages Merriman Curhan Ford & Co. to Evaluate Strategic Alternatives
10/13/2009 7:34:02 AM
More...
|
Vion Pharmaceuticals (VION) to Present at Rodman & Renshaw Healthcare Conference
9/9/2009 9:42:02 AM
More...
|
Vion Pharmaceuticals (VION) Announces Results of the Oncologic Drugs Advisory Committee
9/2/2009 11:00:34 AM
More...
|
|